-
The Negative Affects of Clinical Trials Funded By Drug Companies
How Did We Get Into This Situation, And How Can We Get Out: Two Recent Editorials In December 2005 The New England Journal of Medicine (NEJM) announced that it had learned about "inaccuracies and…
-
Original “First” Vioxx Trial Will Be Nation’s Fourth: Garza v. Merck, et.al.
Next Vioxx Case Goes to Court Late January 2006 In Starr County, Texas The nation’s fourth Vioxx trial against Merck & Co. concerning its recalled painkiller Vioxx is reportedly set to begin, with jury…
-
Global Vioxx Settlement “Unacceptable” To Merck CEO Richard Clark
With Three Vioxx Trials Under Its Belt, Merck Sticks To Its Guns On January 3, 2006 Merck & Co.’s Chief Executive Officer Richard Clark told a Morgan Stanley pharmaceutical conference audience that Merck will…
-
Scios Says Two Deaths In Natrecor Trial Were Not Reported To FDA
Latest Natrecor News Increases Safety Concerns About J&J Heart Failure Drug The Scios unit of Johnson & Johnson (J&J) did not immediately report to the FDA two deaths from a clinical trial, or study,…
-
“iPLEDGE” Registry for Accutane Patients Is Mandatory Starting In 2006
Primary Aim Is To Reduce Number Of Accutane-related Birth Defects Enrollment in the "iPLEDGE’ national registry for the anti-acne drug Accutane is mandatory starting January 1, 2006. This "iPLEDGE" registry concerns any and all…
-
Some Drug Studies On ClinicalTrials.gov Not Completely Transparent
Study In NEJM Details How Drug Companies "Hide" Critical Information A study published in the December 29, 2005 New England Journal of Medicine (NEJM), "Trial Registration at ClinicalTrials.gov between May and October 2005", discusses…
